FDA Adverse Event Malfunction Summary report: N

T2BACTERIA PANEL

MDR report key: 19882662 · Received August 1, 2024

Report

Report Number
3010097867-2024-00008
Event Type
Malfunction
Date Received
August 1, 2024
Report Date
August 1, 2024
Manufacturer
T2 BIOSYSTEMS, INC.
Product Code
QBX
PMA / PMN Number
K233184
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CUSTOMER HAS INDICATED THAT THE COLLECTION OF THE WHOLE BLOOD SAMPLE USED TO RUN THE T2BACTERIA PANEL MAY NOT ALWAYS OCCUR CONCURRENTLY WITH BLOOD CULTURE SAMPLE COLLECTION, AND THAT ANTIBIOTIC THERAPY MAY HAVE BEEN INITIATED AFTER BLOOD CULTURE COLLECTION BUT PRIOR TO COLLECTION OF T2BACTERIA PANEL SAMPLE.

Description of Event or Problem · 0

T2BIOSYSTEMS RECEVIVED INFORMATION FROM A CUSTOMER REPORTING HISTORICAL DATA WITH INSTANCES OF POTENTIAL FALSE NEGATIVE E. COLI RESULTS USING THE T2BACTERIA PANEL. INCIDENT RATE IS REPORTED AS AROUND 1% OF CASES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2025317 T2BACTERIA PANEL DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM QBX T2 BIOSYSTEMS, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown